Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer is usually estrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) negative. Here, we present a...
Saved in:
| Published in | Journal of breast cancer Vol. 22; no. 2; pp. 336 - 340 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
Korean Breast Cancer Society
01.06.2019
한국유방암학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1738-6756 2092-9900 2092-9900 |
| DOI | 10.4048/jbc.2019.22.e17 |
Cover
| Abstract | Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer is usually estrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) negative. Here, we present a case of HER2-positive MC with an unusual signet ring cell differentiation. It is very rare that a breast tumor consists entirely of signet ring cells. The tumor showed pathologic complete response (pCR) after neoadjuvant chemotherapy with trastuzumab and pertuzumab. pCR of HER2-positive MC has rarely been described in literature. It is important to consider the biological heterogeneity of MCs for effective management. |
|---|---|
| AbstractList | Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer is usually estrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) negative. Here, we present a case of HER2-positive MC with an unusual signet ring cell differentiation. It is very rare that a breast tumor consists entirely of signet ring cells. The tumor showed pathologic complete response (pCR) after neoadjuvant chemotherapy with trastuzumab and pertuzumab. pCR of HER2-positive MC has rarely been described in literature. It is important to consider the biological heterogeneity of MCs for effective management. Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer is usually estrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) negative. Here, we present a case of HER2-positive MC with an unusual signet ring cell differentiation. It is very rare that a breast tumor consists entirely of signet ring cells. The tumor showed pathologic complete response (pCR) after neoadjuvant chemotherapy with trastuzumab and pertuzumab. pCR of HER2-positive MC has rarely been described in literature. It is important to consider the biological heterogeneity of MCs for effective management. KCI Citation Count: 3 Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer is usually estrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) negative. Here, we present a case of HER2-positive MC with an unusual signet ring cell differentiation. It is very rare that a breast tumor consists entirely of signet ring cells. The tumor showed pathologic complete response (pCR) after neoadjuvant chemotherapy with trastuzumab and pertuzumab. pCR of HER2-positive MC has rarely been described in literature. It is important to consider the biological heterogeneity of MCs for effective management.Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer is usually estrogen receptor/progesterone receptor positive and human epidermal growth factor receptor 2 (HER2) negative. Here, we present a case of HER2-positive MC with an unusual signet ring cell differentiation. It is very rare that a breast tumor consists entirely of signet ring cells. The tumor showed pathologic complete response (pCR) after neoadjuvant chemotherapy with trastuzumab and pertuzumab. pCR of HER2-positive MC has rarely been described in literature. It is important to consider the biological heterogeneity of MCs for effective management. |
| Author | Cho, Eun Yoon Cho, Soo Youn Jang, Yunjeong |
| AuthorAffiliation | Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea |
| AuthorAffiliation_xml | – name: Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea |
| Author_xml | – sequence: 1 givenname: Yunjeong orcidid: 0000-0002-8997-9686 surname: Jang fullname: Jang, Yunjeong organization: Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea – sequence: 2 givenname: Eun Yoon orcidid: 0000-0001-5849-3600 surname: Cho fullname: Cho, Eun Yoon organization: Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea – sequence: 3 givenname: Soo Youn orcidid: 0000-0001-9714-7575 surname: Cho fullname: Cho, Soo Youn organization: Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31281734$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002474043$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNqNkU1r3DAQhk1JaTZpz70VHVvobiRZtuxLIbj5grSFbUqPQiuP1trYkiPLu-Qn9V9WzqafUOhpBuZ95x3mOUoOrLOQJC8JXjDMipPNSi0oJuWC0gUQ_iSZUVzSeVlifJDMCE-Lec6z_DA5GoYNxjlLOX-WHKaEFnHIZsm3y7GTFp31pgbfyRZdeLcLDTqXKjiPlqCgnxo6791ggtkC-jAqY904oEr6qesk2plo-WzWFgJaGrtGFbQtem-0Bg82GBmMs2_R18aoqGvcDmpUua5vIUDMGHpnB0BSB_DoIzhZb8attAFVDXQuNOBlf_88eaplO8CLx3qcfDk_u6ku59efLq6q0-u5YpSHOdMsz0nNWMZLXZcFpwXNCgmcZpBhneFyVTLNV2nNy3pFCK0ZYaC0ynSR1vFBx8mb_V7rtbhVRjhpHuraiVsvTpc3VyLL49YURy3ea0fby_udbFvRe9NJfy8IFhMhEQmJiZCgVERC0fJub-nHVQe1iu_x8pdtCvtzYk0To7ciz0rOyJT5-nGBd3cjDEF0ZlDx39JCpBJzsrSgeUrSKH31e9bPkB_4o-BkL1DeDYMH_R_nZ385lAkPeOOxpv2n7zvWqtek |
| CitedBy_id | crossref_primary_10_1016_j_asjsur_2022_05_069 crossref_primary_10_1016_j_amsu_2020_02_010 crossref_primary_10_3390_ijms25053009 crossref_primary_10_1007_s10549_020_05550_4 crossref_primary_10_4132_jptm_2019_10_24 |
| Cites_doi | 10.1016/j.clbc.2012.11.007 10.1016/S0140-6736(16)32417-5 10.1097/PAT.0b013e3283437cac 10.1007/s10549-016-3682-6 10.1002/path.2763 10.4132/jptm.2016.08.17 10.4048/jbc.2011.14.4.308 10.1016/j.prp.2015.05.003 10.1007/BF02303864 10.1111/his.13451 10.1093/ajcp/73.1.31 10.1136/jcp.2010.082495 10.1371/journal.pone.0164921 10.18632/oncotarget.8778 |
| ContentType | Journal Article |
| Copyright | 2019 Korean Breast Cancer Society 2019 Korean Breast Cancer Society |
| Copyright_xml | – notice: 2019 Korean Breast Cancer Society 2019 Korean Breast Cancer Society |
| DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY ACYCR |
| DOI | 10.4048/jbc.2019.22.e17 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2092-9900 |
| EndPage | 340 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_5628230 10.4048/jbc.2019.22.e17 PMC6597410 31281734 10_4048_jbc_2019_22_e17 |
| Genre | Case Reports |
| GroupedDBID | --- 5-W 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK DU5 EF. GROUPED_DOAJ HYE KQ8 M48 O5R O5S PGMZT RPM NPM 7X8 5PM ADTOC UNPAY ACYCR |
| ID | FETCH-LOGICAL-c427t-4f4661d44579fd98728258ae725e50f509b94f7b3d79db112d414ecfc5f83d643 |
| IEDL.DBID | M48 |
| ISSN | 1738-6756 2092-9900 |
| IngestDate | Sun Mar 09 07:51:15 EDT 2025 Wed Oct 01 15:37:27 EDT 2025 Thu Aug 21 18:45:13 EDT 2025 Wed Oct 01 14:27:48 EDT 2025 Thu Jan 02 22:50:29 EST 2025 Tue Jul 01 01:56:43 EDT 2025 Thu Apr 24 22:58:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Adenocarcinoma, mucinous Neoadjuvant therapy Breast neoplasms Receptor, ErbB-2 Carcinoma, signet ring cell |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c427t-4f4661d44579fd98728258ae725e50f509b94f7b3d79db112d414ecfc5f83d643 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 https://ejbc.kr/search.php?where=aview&id=10.4048/jbc.2019.22.e17&code=0096JBC&vmode=FULL |
| ORCID | 0000-0001-5849-3600 0000-0002-8997-9686 0000-0001-9714-7575 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4048/jbc.2019.22.e17 |
| PMID | 31281734 |
| PQID | 2253826313 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_5628230 unpaywall_primary_10_4048_jbc_2019_22_e17 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6597410 proquest_miscellaneous_2253826313 pubmed_primary_31281734 crossref_primary_10_4048_jbc_2019_22_e17 crossref_citationtrail_10_4048_jbc_2019_22_e17 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-06-01 |
| PublicationDateYYYYMMDD | 2019-06-01 |
| PublicationDate_xml | – month: 06 year: 2019 text: 2019-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Journal of breast cancer |
| PublicationTitleAlternate | J Breast Cancer |
| PublicationYear | 2019 |
| Publisher | Korean Breast Cancer Society 한국유방암학회 |
| Publisher_xml | – name: Korean Breast Cancer Society – name: 한국유방암학회 |
| References | Didonato (10.4048/jbc.2019.22.e17_ref15) 2018; 72 Ranade (10.4048/jbc.2019.22.e17_ref5) 2010; 63 Fu (10.4048/jbc.2019.22.e17_ref7) 2016; 11 Loibl (10.4048/jbc.2019.22.e17_ref2) 2017; 389 Bae (10.4048/jbc.2019.22.e17_ref3) 2011; 14 Ross (10.4048/jbc.2019.22.e17_ref9) 2016; 155 Bartosch (10.4048/jbc.2019.22.e17_ref10) 2015; 211 Baretta (10.4048/jbc.2019.22.e17_ref14) 2013; 13 Lacroix-Triki (10.4048/jbc.2019.22.e17_ref6) 2010; 222 Hull (10.4048/jbc.2019.22.e17_ref11) 1980; 73 Leung (10.4048/jbc.2019.22.e17_ref13) 2011; 43 Lakhani (10.4048/jbc.2019.22.e17_ref1) 2012 Pan (10.4048/jbc.2019.22.e17_ref4) 2016; 7 Kim (10.4048/jbc.2019.22.e17_ref12) 2017; 51 Avisar (10.4048/jbc.2019.22.e17_ref8) 1998; 5 |
| References_xml | – volume: 13 start-page: 156 year: 2013 ident: 10.4048/jbc.2019.22.e17_ref14 publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2012.11.007 – volume: 389 start-page: 2415 year: 2017 ident: 10.4048/jbc.2019.22.e17_ref2 publication-title: Lancet doi: 10.1016/S0140-6736(16)32417-5 – volume: 43 start-page: 282 year: 2011 ident: 10.4048/jbc.2019.22.e17_ref13 publication-title: Pathology doi: 10.1097/PAT.0b013e3283437cac – volume: 155 start-page: 405 year: 2016 ident: 10.4048/jbc.2019.22.e17_ref9 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-016-3682-6 – volume: 222 start-page: 282 year: 2010 ident: 10.4048/jbc.2019.22.e17_ref6 publication-title: J Pathol doi: 10.1002/path.2763 – volume: 51 start-page: 176 year: 2017 ident: 10.4048/jbc.2019.22.e17_ref12 publication-title: J Pathol Transl Med doi: 10.4132/jptm.2016.08.17 – volume: 14 start-page: 308 year: 2011 ident: 10.4048/jbc.2019.22.e17_ref3 publication-title: J Breast Cancer doi: 10.4048/jbc.2011.14.4.308 – volume: 211 start-page: 588 year: 2015 ident: 10.4048/jbc.2019.22.e17_ref10 publication-title: Pathol Res Pract doi: 10.1016/j.prp.2015.05.003 – volume: 5 start-page: 447 year: 1998 ident: 10.4048/jbc.2019.22.e17_ref8 publication-title: Ann Surg Oncol doi: 10.1007/BF02303864 – volume: 72 start-page: 965 year: 2018 ident: 10.4048/jbc.2019.22.e17_ref15 publication-title: Histopathology doi: 10.1111/his.13451 – volume: 73 start-page: 31 year: 1980 ident: 10.4048/jbc.2019.22.e17_ref11 publication-title: Am J Clin Pathol doi: 10.1093/ajcp/73.1.31 – volume-title: WHO Classification of Tumours of the Breast year: 2012 ident: 10.4048/jbc.2019.22.e17_ref1 – volume: 63 start-page: 1043 year: 2010 ident: 10.4048/jbc.2019.22.e17_ref5 publication-title: J Clin Pathol doi: 10.1136/jcp.2010.082495 – volume: 11 start-page: e0164921 year: 2016 ident: 10.4048/jbc.2019.22.e17_ref7 publication-title: PLoS One doi: 10.1371/journal.pone.0164921 – volume: 7 start-page: 38864 year: 2016 ident: 10.4048/jbc.2019.22.e17_ref4 publication-title: Oncotarget doi: 10.18632/oncotarget.8778 |
| SSID | ssj0064377 |
| Score | 2.1708438 |
| Snippet | Mucinous carcinoma (MC) is a rare subtype of breast cancer, which is composed of tumor cells floating in the abundant extracellular mucin. This form of cancer... |
| SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 336 |
| SubjectTerms | Case Report 일반외과학 |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF3RVAJeuF_CTQviASTsxOt1bD-WpKFUSlRRIop4WO3NTRpjR6lNFf6Iv2TGdlKqghAoD06UcVaOz-6c8cyeIeSlryXqzCnHhh5zOFASR3EtnShRgYrgFVdC2qNxb2_C94-Co_OqSnuitDtfdg5XmVyc2s5AFrJzMBhWR6Tb-2_7HbBxsAbd77kLk2yR7R4ml1pkezI-2Plc7YCEWQxMuOos142ZA0tut9b14ahTi4OA44tdxlxbtSo7d0lb2TL5Hdu8XDR5rcwWcnUm0_QXjzS8Sb6s9_XUhShztyyUq79flnn8j4u9RW40RJXu1Mi6Ta7Y7A65OmpS8XfJj-rxP93FDrOwuKf0HQT0xZQOqwY-FOioXeAb5tR1Yd8sHZVwal6e0j42MMryr5LiY2B6ODvObEE_gBelfZumdNB0bSlq3Lyhn6YzDXbT_MwaiksYoM3CGFV9r6VVo3M6trk0JyWEBgVFHYRmb9nqHpkMdz_295ym74OjOQsLhyccWIPhPAjjxMRRiPtrI2lDFtigmwDFAQQlofJNGBsFhNFwj1ud6CCJfAMU6z5pZXlmHxKaeEk30lEYxRAIa2OU1AxcjWa-Vr5SXpu461svdCOKjr05UgHBEWJFwP8vECuCMQFYaZNXmxMWtR7In01fAJbEXM8Eanjj8TgX86WASOW9AN6JOc42eb6GmoCJjdkamVm4FfAj4ItYz_f8NnlQQ28zoo_5z9DnbRJeAOXGAAe8-E02m1bi4T2MID0Y9_UGvn-7kEf_YPuYXMdPdTHdE9IqlqV9CrStUM-a-fkTm5FBTQ priority: 102 providerName: Unpaywall |
| Title | Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31281734 https://www.proquest.com/docview/2253826313 https://pubmed.ncbi.nlm.nih.gov/PMC6597410 http://ejbc.kr/Synapse/Data/PDFData/0096JBC/jbc-22-336.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002474043 |
| UnpaywallVersion | publishedVersion |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Breast Cancer, 2019, 22(2), 90, pp.336-340 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2092-9900 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064377 issn: 2092-9900 databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2092-9900 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064377 issn: 2092-9900 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2092-9900 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064377 issn: 2092-9900 databaseCode: DIK dateStart: 20110101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2092-9900 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064377 issn: 2092-9900 databaseCode: 5-W dateStart: 20050101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2092-9900 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064377 issn: 2092-9900 databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2092-9900 dateEnd: 20250630 omitProxy: true ssIdentifier: ssj0064377 issn: 2092-9900 databaseCode: M48 dateStart: 20110301 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbYJo29TPwm_KgM4gEkEi2OUydPaCorA6kVAirGkxU7ztotJF2XMPon8V9y56SBiiIk1IdWquNT-51z3_mc-wh5FugE-8wp1wifuRwoiau4TtwoU6GK4BXbRtqjcf94wt-dhCe_5IDaP_ByY2qHelKTRe59v1i-ggUP_NXj2Hb2TGEvQj_2GPOML7bIDoQlhi4-4l1JAQtUVmlFwAoHltxv-vxsmmCP7AZYYBIBX4tWW8Ui20RE_zxPeb0u5snyKsnz34LV8AbZb1kmPWzc4ia5ZopbZHfU1tFvkx92754eoTws3Jlz-gay8WpKh1Z9hwKXNHP8wNzmUNc3Q0c1XFrWl3SA6kNF-TWhuIdLP85OC1PRDxAC6cDkOX3dSq5UDegv6efpTMO4aXllUor3H3AVAzbs4VxDrUo5HZsySc9q4PUVxSYG7YNhyztkMjz6NDh2W9EGV3MmKpdnHEJ-ynko4iyNI4EPx0aJESw04UEG_ATgz4QKUhGnCtheyn1udKbDLApSQOku2S7KwtwnNPOzg0hHIoohi9VpqhLNIE5oFmgVKOU7xFuBI3Xb0RyFNXIJmQ0CKwFYicBKxiQA65Dn3QXzppnH34c-BbTluZ5JbMCN76elPF9ISDPeSiCNWKB0yJOVM0hYlVhqSQoDUMAkEEhYP_ADh9xrnKOzuPIth4g1t-kGoMH1b4rZ1Hb-7mP654PdF52D_euHPPhvKw_JHs7TnIt7RLarRW0eAwOrVM_uXPTs-urZDbIe2ZmM3x9--QnKUTXt |
| linkProvider | Scholars Portal |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF3RVAJeuF_CTQviASTsxOt1bD-WpKFUSlRRIop4WO3NTRpjR6lNFf6Iv2TGdlKqghAoD06UcVaOz-6c8cyeIeSlryXqzCnHhh5zOFASR3EtnShRgYrgFVdC2qNxb2_C94-Co_OqSnuitDtfdg5XmVyc2s5AFrJzMBhWR6Tb-2_7HbBxsAbd77kLk2yR7R4ml1pkezI-2Plc7YCEWQxMuOos142ZA0tut9b14ahTi4OA44tdxlxbtSo7d0lb2TL5Hdu8XDR5rcwWcnUm0_QXjzS8Sb6s9_XUhShztyyUq79flnn8j4u9RW40RJXu1Mi6Ta7Y7A65OmpS8XfJj-rxP93FDrOwuKf0HQT0xZQOqwY-FOioXeAb5tR1Yd8sHZVwal6e0j42MMryr5LiY2B6ODvObEE_gBelfZumdNB0bSlq3Lyhn6YzDXbT_MwaiksYoM3CGFV9r6VVo3M6trk0JyWEBgVFHYRmb9nqHpkMdz_295ym74OjOQsLhyccWIPhPAjjxMRRiPtrI2lDFtigmwDFAQQlofJNGBsFhNFwj1ud6CCJfAMU6z5pZXlmHxKaeEk30lEYxRAIa2OU1AxcjWa-Vr5SXpu461svdCOKjr05UgHBEWJFwP8vECuCMQFYaZNXmxMWtR7In01fAJbEXM8Eanjj8TgX86WASOW9AN6JOc42eb6GmoCJjdkamVm4FfAj4ItYz_f8NnlQQ28zoo_5z9DnbRJeAOXGAAe8-E02m1bi4T2MID0Y9_UGvn-7kEf_YPuYXMdPdTHdE9IqlqV9CrStUM-a-fkTm5FBTQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+Epidermal+Growth+Factor+Receptor+2-positive+Mucinous+Carcinoma+with+Signet+Ring+Cell+Differentiation%2C+Which+Showed+Complete+Response+after+Neoadjuvant+Chemotherapy&rft.jtitle=Journal+of+breast+cancer&rft.au=Jang%2C+Yunjeong&rft.au=Cho%2C+Eun+Yoon&rft.au=Cho%2C+Soo+Youn&rft.date=2019-06-01&rft.pub=Korean+Breast+Cancer+Society&rft.issn=1738-6756&rft.eissn=2092-9900&rft.volume=22&rft.issue=2&rft.spage=336&rft.epage=340&rft_id=info:doi/10.4048%2Fjbc.2019.22.e17&rft_id=info%3Apmid%2F31281734&rft.externalDocID=PMC6597410 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6756&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6756&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6756&client=summon |